Managers / Q4 2018 · view latest →
Mohican Financial Management, LLC
CIK 0001367663 · 21 RIVER RD, SUITE 2100, WILTON, CT, 06897 · 203-423-8029
Summary
Mohican Financial Management, LLC reported $24M in U.S.-listed holdings across 30 positions for Q4 2018.
Its largest position, Carbonite, represents 9.8% of the portfolio.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- US DOMESTIC · 98.5% · $24M
- GLOBAL · 1.5% · $355,000
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CARBONITE INC | NEW | +2.00M | 2.00M | +$2M | $2M |
| SILICON LABORATORIES INC | NEW | +1.50M | 1.50M | +$2M | $2M |
| KAMAN CORP | NEW | +1.42M | 1.42M | +$2M | $2M |
| SERVICENOW INC | NEW | +1.00M | 1.00M | +$1M | $1M |
| HELIX ENERGY SOLUTIONS GRP I | NEW | +1.50M | 1.50M | +$1M | $1M |
| HARMONIC INC | NEW | +1.25M | 1.25M | +$1M | $1M |
| INFINERA CORPORATION | NEW | +1.50M | 1.50M | +$1M | $1M |
| EXACT SCIENCES CORP | NEW | +1.00M | 1.00M | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2018
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | CARBONITE INC | NOTE 2.500% 4/0 | 9.84% | $2M | 2.00M |
| 2 | SILICON LABORATORIES INC | NOTE 1.375% 3/0 | 6.55% | $2M | 1.50M |
| 3 | KAMAN CORP | NOTE 3.250% 5/0 | 6.24% | $2M | 1.42M |
| 4 | SERVICENOW INC | NOTE 6/0 | 5.79% | $1M | 1.00M |
| 5 | HELIX ENERGY SOLUTIONS GRP I | NOTE 4.125% 9/1 | 5.67% | $1M | 1.50M |
| 6 | HARMONIC INC | NOTE 4.000%12/0 | 5.45% | $1M | 1.25M |
| 7 | INFINERA CORPORATION | NOTE 2.125% 9/0 | 4.54% | $1M | 1.50M |
| 8 | EXACT SCIENCES CORP | DBCV 1.000% 1/1 | 4.50% | $1M | 1.00M |
| 9 | PACIRA PHARMACEUTICALS INC | NOTE 2.375% 4/0 | 4.12% | $998,000 | 1.00M |
| 10 | RETROPHIN INC | NOTE 2.500% 9/1 | 4.06% | $984,000 | 1.10M |
| 11 | II VI INC | NOTE 0.250% 9/0 | 3.99% | $968,000 | 1.00M |
| 12 | TEAM INC | NOTE 5.000% 8/0 | 3.98% | $964,000 | 967.0K |
| 13 | ALDER BIOPHARMACEUTICALS INC | NOTE 2.500% 2/0 | 3.30% | $800,000 | 1.00M |
| 14 | VEECO INSTRS INC DEL | NOTE 2.700% 1/1 | 3.08% | $747,000 | 1.00M |
| 15 | DEXCOM INC | NOTE 0.750% 5/1 | 2.91% | $705,000 | 525.0K |
| 16 | NOVAVAX INC | NOTE 3.750% 2/0 | 2.53% | $613,000 | 1.00M |
| 17 | ENCORE CAP GROUP INC | NOTE 2.875% 3/1 · NOTE 3.000% 7/0 | 2.29% | $555,000 | 647.0K |
| 18 | SILVER STD RES INC | NOTE 2.875% 2/0 | 2.13% | $516,000 | 520.0K |
| 19 | THERAVANCE BIOPHARMA INC | NOTE 3.250%11/0 | 2.12% | $514,000 | 500.0K |
| 20 | FLEXION THERAPEUTICS INC | NOTE 3.375% 5/0 | 2.09% | $508,000 | 625.0K |
| 21 | NEW MTN FIN CORP | NOTE 5.750% 8/1 | 2.00% | $485,000 | 500.0K |
| 22 | FIREEYE INC | NOTE 1.625% 6/0 | 1.88% | $457,000 | 500.0K |
| 23 | AVID TECHNOLOGY INC | NOTE 2.000% 6/1 | 1.85% | $448,000 | 500.0K |
| 24 | ENCORE CAP EUROPE FIN LTD | NOTE 4.500% 9/0 | 1.64% | $398,000 | 500.0K |
| 25 | TIMKENSTEEL CORP | NOTE 6.000% 6/0 | 1.57% | $380,000 | 365.0K |
| 26 | GLOBAL EAGLE ENTMT INC | NOTE 2.750% 2/1 | 1.55% | $375,000 | 500.0K |
| 27 | ACETO CORP | NOTE 2.000%11/0 | 1.46% | $355,000 | 500.0K |
| 28 | INSMED INC | NOTE 1.750% 1/1 | 1.46% | $355,000 | 500.0K |
| 29 | FLUIDIGM CORP DEL | NOTE 2.750% 2/0 | 1.43% | $347,000 | 305.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2021 | $256M | 70 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $154M | 51 | Apr 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $98M | 46 | Jan 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $80M | 47 | Oct 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $55M | 40 | Jul 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $70M | 47 | Apr 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $64M | 40 | Jan 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $65M | 46 | Oct 25, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $68M | 49 | Jul 11, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $31M | 31 | Apr 23, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $24M | 30 | Jan 29, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.